Schedule
The event will be held on Nov 16th.
Agenda (Timezone EST):
8:00am – 8:45 am Registration and Coffee
8:55 am - 9:30 am – Overview of the Agenda and Welcome Remarks
8:55am - 9am Ilknur Icke, PhD. Director of Applied Machine Learning, Bayer
9am - 9:15am Emmanuelle di Tomaso, PhD Global Head, Translational Sciences Oncology, Bayer
9:15am - 9:30am Sai Jasti, SVP, Head of Data Science and AI, Bayer
9:30 am - 11:00am Session 1. Understanding health and disease for Precision Health and Precision Medicine
Moderator: Farzaneh Nasirian, PhD. Applied Machine Learning, Bayer
9:30am - 10:00 am Virginia Savova, PhD. Senior Director, Global Head of Single-cell Biology, Sanofi
From Single-cell Biology To Cell-Centric Drug Discovery
10am - 10:30am Matthew Bernstein, PhD. Principal Scientist, Immunitas Therapeutics
Annotating cell types and cell states in single-cell omics data: a challenging problem
10:30am - 11am Shantanu Singh, Ph.D. Senior Group Leader at the Broad Institute
Finding disease phenotypes and candidate therapeutics using images: Cell Painting
Coffee Break and Networking - refreshments will be served (30 mins)
11:30am- 1:00pm Session 2. Designing Therapeutics for Precision Medicine
Moderator: Matteo Aldeghi, PhD. Director of Machine Learning Research, Bayer
11:30 am - 12pm Elizabeth Wood, PhD. President and Chief Executive Officer, JURA Bio, Inc
Variational Synthesis Atlas of Human T Cell Repertoires (VISTA-T): Generative Library Design Enables Large Scale Discovery of Therapeutically Relevant TCRs
12pm - 12:30pm Sherlock Hu, PhD. CIO, GV20 Therapeutics
AI for Target Identification and Antibody Discovery
12:30pm - 1pm Michal Warchol, PhD. Executive Vice President, Ardigen
Multimodal approach to phenotype-guided virtual screening of small molecules
1:00pm – 2:00pm Lunch Break - Poster and Networking Session at BRIC 6th floor (lunch will be provided)
Participating companies: Ardigen, Leal Health, Florence Health, Superluminal Medicines
2:00pm - 3:30pm Session 3. Conducting Better Clinical Trials for Precision Medicine
Moderator: Sara Rahmati, PhD. Applied Machine Learning, Bayer
2pm - 2:30pm Gustavo Arango-Argoty, Ph.D. Associate Director, Applied Data Science, AstraZeneca
Pretrained transformers applied to clinical studies improve predictions of treatment efficacy and associated biomarkers
2:30pm - 3pm James Lindsay, PhD. Director of Software Engineering, Department of Data Science, Dana-Farber Cancer Institute
Leveraging artificial intelligence predictions of treatment change to time out reach for enrollment in precision medicine clinical trials
3pm - 3:30pm Charles Fisher, PhD. CEO, Unlearn.AI
Enabling Efficient Clinical Trials with Generative Models for Clinical Timeseries
Coffee Break and Networking - refreshments will be provided (30 mins)
4pm - 4:20pm Fireside Chat: Fiona Mack, Head of Bayer Co.Lab and Dylan Morris, Managing Director, Insight Partners
Emerging Trends from a Venture Capitalist Perspective
4:20pm - 4:25pm Closing Remarks
Ming Tommy Tang, PhD. Director of Computational Biology, Immunitas Therapeutics
4:25pm End of workshop